• 2019-07
  • 2019-08
  • 2019-09
  • 2019-10
  • 2019-11
  • 2020-03
  • 2020-07
  • 2020-08
  • br N M Saarinen A Warri


    [15] N.M. Saarinen, A. Warri, M. Airio, A. Smeds, S. Makela, Role of dietary lignans in the reduction of breast cancer risk, Mol. Nutr. Food Res. 51 (2007) 857–866. [16] R. Velázquez-Jiménez, J.M. Torres-Valencia, C.M. Cerda-García-Rojas, J.D. Hernández-Hernández, L.U. Román-Marín, J.J. Manríquez-Torres, M.A. Gómez-Hurtado, A. Valdez-Calderón, V. Motilva, S. García-Mauriño, Absolute configuration of podophyllotoxin related lignans from Bursera fagaroides using vi-brational circular dichroism, Phytochemistry 72 (2011) 2237–2243.
    [18] M. Maldini, P. Montoro, S. Piacente, C. Pizza, Phenolic compounds from Bursera simaruba Sarg. bark: phytochemical investigation and quantitative analysis by tandem mass spectrometry, Phytochemistry 70 (2009) 641–649.
    [26] R. Geran, Protocols for screening chemical agents and natural products against animal tumors and other biological systems, Cancer Chemoth. Rep. 3 (1972) 17–27. [27] T.V.T. Le, P.H. Nguyen, H.S. Choi, J.-L. Yang, K.W. Kang, S.-G. Ahn, W.K. Oh, Diarylbutane-type lignans from Myristica fragrans (nutmeg) show the cytotoxicity against breast cancer cells through activation of AMP-activated protein kinase, Nat. Prod. Sci. 23 (2017) 21–28.
    K. Lorenz, E.H. Lee, M.H. Barcellos-Hoff, O.W. Petersen, The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expression, Mol. Oncol. 1 (2007) 84–96.
    [32] J.J. Campbell, A. Husmann, R.D. Hume, C.J. Watson, R.E. Cameron, Development of three-dimensional collagen scaffolds with controlled architecture for cell mi-gration studies using breast cancer cell lines, Biomaterials 114 (2017) 34–43.
    [33] A. Tedasen, S. Choomwattana, P. Graidist, V. Tipmanee, Structure-guided cancer blockade between bioactive bursehernin and proteins: molecular docking and molecular dynamics study, J. Mol. Graph. Model. 74 (2017) 215–224.
    T. Rattanaburee, et al.
    B. Sripa, S. Pinlaor, B.B. Aggarwal, Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell sig-naling pathways, Carcinogenesis 32 (2011) 1372–1380.
    R. Velmurugan, A. Balakrishnan, Novel substituted methylenedioxy lignan sup-presses proliferation of cancer cells by inhibiting telomerase and activation of c-myc and caspases leading to apoptosis, Br. J. Cancer 87 (2002) 98. [40] Y. Zhou, Y.E. Liu, J. Cao, G. Zeng, C. Shen, Y. Li, M. Zhou, Y. Chen, W. Pu, L. Potters, Vitexins, nature-derived lignan compounds, induce apoptosis and suppress tumor growth, Clin. Cancer Res. 15 (2009) 5161–5169.
    [49] Y. Koh, K. Nishio, N. Saijo, Mechanisms of action of cancer chemotherapeutic agents: topoisomerase inhibitors, The Cancer Handbook, (2005).
    Contents lists available at ScienceDirect
    Toxicology Reports
    journal homepage:
    Anticancer effect of fucoidan on cell proliferation, 78110-38-0 progression, genetic damage and apoptotic cell death in HepG2 cancer cells 
    P. Arumugama, , K. Arunkumarb, L. Sivakumarc, M. Murugand, K. Murugana
    a Department of Zoology, School of Life Science, Bharathiar University, Coimbatore, 641 046, Tamil Nadu, India b Department of Plant Science, School of Biological Sciences, Central University of Kerala, Riverside Transit Campus, Padanakkad, 671 314, Kasaragod, Kerala, India c Department of Environmental Science, Periyar University, Salem, 636011, Tamil Nadu, India d Department of Microbial Technology, School of Biological Science, Madurai Kamaraj University, Madurai, 625 021, Tamil Nadu, India
    HepG2 cells
    Cell cycle
    Genetic damage
    Natural biopolymer 
    The centre of the attraction of this article is inevitably associated with fucoidan polymers in terms of brown seaweed such as Turbinaria conoides. Fucoidan is a sulphated polysaccharide constitutes fucose as a major principle sugar along with other monosugars such as glucuronic acid, xylose and galactose. The core value of fucoidan in terms of various cancer types were substantially exhibited through targeting the key apoptotic molecules and subsequently mitigate the toxicity that are essentially included in the chemotherapeutic agents and radiation. The pragmatic investigation about the anti-cancer effect of fucoidan in a hepatoblastoma-derived (HepG2) cell line was thoroughly analyzed by the typical techniques such as cell viability, colony formation, cell migration, cell cycle progression, genetic damage and apoptosis along with their nuclear morphology and mi-tochondrial membrane potential. Following the analyzes, the cell viability was precisely evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. And hence, cell cycle arrest and apoptosis was appropriately examined staining with propidium iodide (PI) and annexin V-fluorescein isothiocyante (FITC) by flowcytometer, respectively. Primarily, genetic damage by fucoidan in HepG2 cell line was evaluated by following Trevigen’s comet assay kit. In addition, alteration of nuclear content and mitochondrial membrane potential were also detected with Hoechst and mitochondrial membrane potential dye (JC-1: 5,5′6,6′-tetra-chloro-1,1′3,3′tetraethylbenzimi-dazolycarbocyanine iodide) by fluorescence microscopy, respectively. The re-sults of the present study showed that cells constituted with fucoidan/quercetin standard at 50, 100 and 200 μg/ ml exhibited cell viability about 71, 60 & 40/80, 65 & 45%, respectively. The above recorded effect of fucoidan was a concentration-dependant inhibition on the basis of decline in colony forming and cell migration potential of HepG2 cancer cells. Compared with untreated control, fucoidan consituted cells were significantly (p ≤ 0.05) accumulated proliferative cells in the G0/G1 phase of the cell cycle in a concentration dependent manner. Increasing concentration of fucoidan (50,100 and 200 μg/ml) was remarkably enhanced the DNA damage which reflected through tail moment value of 3.8, 7.1 & 12.8 folds with respect to the untreated control. Fucoidan induced total apoptotic cells were observed ∼20–40% at 50–200 μg/ml concentrations. The apoptotic cell formation effected by change in the nuclear content and mitochondrial membrane potential was confirmed in HepG2 cancer cells under fluorescence microscopy. It was eventually concluded that the fucoidan display promising anti-cancer activity against HepG2 cancer cells by promoting the inhibition of cell proliferation, migration and cell arrest on concentration dependent-manner that was well correlated with genetic damage and apoptosis.